Heart Transplantation in a Patient With a Heterotopic Percutaneous Tricuspid Valve Prosthesis: A Case Report

• Published in: Transplantation proceedings Vol. 55; no. 10; pp. 2312 - 2314
• Main Authors: Adsuar-Gómez, Alejandro, Rodríguez-Mora, Felipe, González-Calle, Antonio, Ramos-Barragán, Belén, Rezaei, Kambiz, Sobrino-Márquez, José Manuel, Rangel-Sousa, Diego, Borrego-Domínguez, José Miguel
• Format: Journal Article
• Language: English
• Published: United States 01.12.2023
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/j.transproceed.2023.09.004

The bicaval transcatheter prosthesis (TricValve) allows the treatment of cava reflux in patients with severe tricuspid regurgitation and high surgical risk. It consists of the implantation of 2 self-expanding valves in both vena cava without directly approaching the native tricuspid valve. Heart transplantation in this setting may require some modifications compared with the conventional bicaval technique. We describe the clinical case of a 69-year-old woman with a background of rheumatic mitral valve disease who required a mitral valve replacement a few decades before. Ongoing clinical deterioration with biventricular dysfunction and severe tricuspid regurgitation was treated with a percutaneous bicaval heterotopic self-expanding valve system, with no clinical benefit. The patient underwent an elective heart transplantation. For the surgical approach, venous cannulation was performed percutaneously for both the right internal jugular and right femoral vein. Due to the impossibility of extracting percutaneous caval valves, the biatrial technique was selected for heart implantation. The postoperative course was difficult, but the patient was successfully discharged home 2 months postoperatively. She remains in good clinical condition with normal heart function 1 year after the transplant. To our knowledge, this is the first report describing a heart transplant in a patient with a bicaval transcatheter prosthesis.